Milrinone and esmolol decrease cardiac damage after resuscitation from prolonged cardiac arrest

Acta Anaesthesiologica Scandinavica

Volumn 59, Issue 4, 2015, Pages 465-474

  Zoerner, F ^a,b   Lennmyr, F ^a   Wiklund, L ^a   Martijn, C ^c   Semenas, E ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b Region of Halland   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ESMOLOL; HEMOGLOBIN; MILRINONE; NORADRENALIN; TROPONIN I; VASOPRESSIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOTONIC AGENT; PROPANOLAMINE DERIVATIVE; VASOCONSTRICTOR AGENT; VASOPRESSIN DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DEFIBRILLATION; HEART ARREST; HEART INDEX; HEART INJURY; HEART MUSCLE REPERFUSION; HEART RATE; HEMOGLOBIN DETERMINATION; LONG TERM SURVIVAL; MEAN ARTERIAL PRESSURE; NONHUMAN; PIGLET; PRIORITY JOURNAL; RESUSCITATION; ACID BASE BALANCE; ANIMAL; BLOOD; COMPLICATION; FLUID THERAPY; HEART DISEASES; HEART MUSCLE; MALE; PATHOLOGY; PIG; SURVIVAL;

ACID-BASE EQUILIBRIUM; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CARDIOPULMONARY RESUSCITATION; CARDIOTONIC AGENTS; FLUID THERAPY; HEART ARREST; HEART DISEASES; MALE; MILRINONE; MYOCARDIUM; PROPANOLAMINES; SURVIVAL ANALYSIS; SWINE; TROPONIN I; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 84925257858     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/aas.12480     Document Type: Article

References (35)

1. Bourque D, Daoust R, Huard V, Charneux M,. Beta-blockers for the treatment of cardiac arrest from ventricular fibrillation? Resuscitation 2007; 75: 434-444.
2. Chalkias A, Xanthos T,. Pathophysiology and pathogenesis of post-resuscitation myocardial stunning. Heart Fail Rev 2012; 17: 117-128.
3. Nolan JP, Neumar RW, Adrie C, Aibiki M, Berg RA, Bottiger BW, Callaway C, Clark RS, Geocadin RG, Jauch EC, Kern KB, Laurent I, Longstreth WT, Merchant RM, Morley P, Morrison LJ, Nadkarni V, Peberdy MA, Rivers EP, Rodriguez-Nunez A, Sellke FW, Spaulding C, Sunde K, Hoek TV,. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A scientific statement from the International Liaison Committee on Resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; the Council on Stroke. Resuscitation 2008; 79: 350-379.
4. de Oliveira FC, Feitosa-Filho GS, Ritt LE,. Use of beta-blockers for the treatment of cardiac arrest due to ventricular fibrillation/pulseless ventricular tachycardia: a systematic review. Resuscitation 2012; 83: 674-683.
5. Cuffe MS, Califf RM, Adams KF Jr., Benza R, Bourge R, Colucci WS, Massie BM, O'Connor CM, Pina I, Quigg R, Silver MA, Gheorghiade M,. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 2002; 287: 1541-1547.
6. Rathmell JP, Prielipp RC, Butterworth JF, Williams E, Villamaria F, Testa L, Viscomi C, Ittleman FP, Baisden CE, Royster RL,. A multicenter, randomized, blind comparison of amrinone with milrinone after elective cardiac surgery. Anesth Analg 1998; 86: 683-690.
7. Honerjager P,. Pharmacology of bipyridine phosphodiesterase III inhibitors. Am Heart J 1991; 121: 1939-1944.
8. Banfor PN, Preusser LC, Campbell TJ, Marsh KC, Polakowski JS, Reinhart GA, Cox BF, Fryer RM,. Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs. Am J Physiol Heart Circ Physiol 2008; 294: H238-248.
9. Udeh CI, Diaz-Gomez JL, Anthony D, Satyapriya A, Perez-Protto S, Hata JS,. Recent advances in perioperative anesthetic management update on the role of vasopressin and its effects on outcomes. Curr Pharm Des 2012; 18: 6308-6313.
10. Lindner KH, Prengel AW, Pfenninger EG, Lindner IM, Strohmenger HU, Georgieff M, Lurie KG,. Vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs. Circulation 1995; 91: 215-221.
11. Prengel AW, Lindner KH, Keller A,. Cerebral oxygenation during cardiopulmonary resuscitation with epinephrine and vasopressin in pigs. Stroke 1996; 27: 1241-1248.
12. Aung K, Htay T,. Vasopressin for cardiac arrest: a systematic review and meta-analysis. Arch Intern Med 2005; 165: 17-24.
13. Axelsson B, Johansson G, Abrahamsson P, Gupta A, Tyden H, Wouters P, Haney M,. Milrinone and levosimendan during porcine myocardial ischemia-no effects on calcium overload and metabolism. Acta Anaesthesiol Scand 2013; 57: 719-728.
14. Miclescu A, Basu S, Wiklund L,. Methylene blue added to a hypertonic-hyperoncotic solution increases short-term survival in experimental cardiac arrest. Crit Care Med 2006; 34: 2806-2813.
15. Miclescu A, Basu S, Wiklund L,. Cardio-cerebral and metabolic effects of methylene blue in hypertonic sodium lactate during experimental cardiopulmonary resuscitation. Resuscitation 2007; 75: 88-97.
16. Nolan JP,. Optimizing outcome after cardiac arrest. Curr Opin Crit Care 2011; 17: 520-526.
17. Niemann JT, Garner D, Khaleeli E, Lewis RJ,. Milrinone facilitates resuscitation from cardiac arrest and attenuates postresuscitation myocardial dysfunction. Circulation 2003; 108: 3031-3035.
18. Theochari E, Xanthos T, Papadimitriou D, Demestiha T, Condilis N, Tsirikos-Karapanos N, Tsiftsi K, Papadimitriou L,. Selective beta blockadeimproves the outcome of cardiopulmonary resuscitation in a swine model of cardiac arrest. Ann Ital Chir 2008; 79: 409-414.
19. Larabee TM, Liu KY, Campbell JA, Little CM,. Vasopressors in cardiac arrest: a systematic review. Resuscitation 2012; 83: 932-939.
20. Sandroni C, Cavallaro F, Antonelli M,. Is there still a place for vasopressors in the treatment of cardiac arrest? Crit Care 2012; 16: 213.
21. Nolan JP, Soar J, Zideman DA, Biarent D, Bossaert LL, Deakin C, Koster RW, Wyllie J, Bottiger B,. European Resuscitation Council Guidelines for Resuscitation 2010 Section 1. Executive summary. Resuscitation 2010; 81: 1219-1276.
22. Nolan JP, Soar J, Zideman DA, Biarent D, Bossaert LL, Deakin C, Koster RW, Wyllie J, Bottiger B, Group ERCGW. European Resuscitation Council Guidelines for Resuscitation 2010 Section 1. Executive summary. Resuscitation 2010; 81: 1219-1276.
23. Jacobs IG, Finn JC, Jelinek GA, Oxer HF, Thompson PL,. Effect of adrenaline on survival in out-of-hospital cardiac arrest: a randomised double-blind placebo-controlled trial. Resuscitation 2011; 82: 1138-1143.
24. Geissler HJ, Davis KL, Buja LM, Laine GA, Brennan ML, Mehlhorn U, Allen SJ,. Esmolol and cardiopulmonary bypass during reperfusion reduce myocardial infarct size in dogs. Ann Thorac Surg 2001; 72: 1964-1969.
25. Sidi A, Rush W,. Decreased regional lactate production and output due to intracoronary continuous infusion of esmolol during acute coronary occlusion in dogs. J Cardiothorac Vascular Anesth 1991; 5: 237-242.
26. Roth E, Torok B,. Effect of the ultrashort-acting beta-blocker Brevibloc on free-radical-mediated injuries during the early reperfusion state. Basic Res Cardiol 1991; 86: 422-433.
27. Neumar RW, Nolan JP, Adrie C, Aibiki M, Berg RA, Bottiger BW, Callaway C, Clark RS, Geocadin RG, Jauch EC, Kern KB, Laurent I, Longstreth WT Jr., Merchant RM, Morley P, Morrison LJ, Nadkarni V, Peberdy MA, Rivers EP, Rodriguez-Nunez A, Sellke FW, Spaulding C, Sunde K, Vanden Hoek T,. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council. Circulation 2008; 118: 2452-2483.
28. Caldarone CA, Krukenkamp IB, Burns PG, Misare BD, Gaudette GR, Levitsky S,. Ischemia-dependent efficacy of phosphodiesterase inhibition. Ann Thorac Surg 1994; 57: 540-545.
29. Ong ME, Tiah L, Leong BS, Tan EC, Ong VY, Tan EA, Poh BY, Pek PP, Chen Y,. A randomised, double-blind, multi-centre trial comparing vasopressin and adrenaline in patients with cardiac arrest presenting to or in the Emergency Department. Resuscitation 2012; 83: 953-960.
30. Fothergill RT, Watson LR, Chamberlain D, Virdi GK, Moore FP, Whitbread M,. Increases in survival from out-of-hospital cardiac arrest: a five year study. Resuscitation 2013; 84: 1089-1092.
31. Hollenberg J, Svensson L, Rosenqvist M,. Out-of-hospital cardiac arrest: 10 years of progress in research and treatment. J Intern Med 2013; 273: 572-583.
32. Semenas E, Nozari A, Sharma HS, Basu S, Rubertsson S, Wiklund L,. Sex differences in cerebral injury after severe haemorrhage and ventricular fibrillation in pigs. Acta Anaesthesiol Scand 2010; 54: 343-353.
33. Wiklund L, Sharma HS, Basu S,. Circulatory arrest as a model for studies of global ischemic injury and neuroprotection. Ann N Y Acad Sci 2005; 1053: 205-219.
34. Wiklund L, Zoerner F, Semenas E, Miclescu A, Basu S, Sharma HS,. Improved neuroprotective effect of methylene blue with hypothermia after porcine cardiac arrest. Acta Anaesthesiol Scand 2013; 57: 1073-1082.
35. Semenas E, Nozari A, Wiklund L,. Sex differences in cardiac injury after severe haemorrhage and ventricular fibrillation in pigs. Resuscitation 2010; 81: 1718-1722.